BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29332451)

  • 1. PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy.
    Zhang X; Hu Q; Chen Y; Li M; Yin H; Zhou C; Li G; Hou J
    Technol Cancer Res Treat; 2017 Dec; 16(6):1168-1172. PubMed ID: 29332451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk.
    Joung JY; Lee YS; Park S; Yoon H; Lee SJ; Park WS; Seo HK; Chung J; Kim SY; Hong SH; Kim JS; Lee KH
    J Urol; 2011 Jun; 185(6):2112-8. PubMed ID: 21497359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Ma W; Zeng G; Qi D
    J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
    Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
    Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
    Fawzy MS; Mohamed RH; Elfayoumi AR
    Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population.
    Wang S; Wu S; Zhu H; Ding B; Cai Y; Ni J; Wu Q; Meng Q; Zhang X; Zhang C; Li X; Wang M; Chen R; Jin H; Zhang Z
    Sci Rep; 2016 Mar; 6():23465. PubMed ID: 27001215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSCA rs2294008 Polymorphism with Increased Risk of Cancer.
    Geng P; Li J; Wang N; Ou J; Xie G; Liu C; Zhao X; Xiang L; Liao Y; Liang H
    PLoS One; 2015; 10(8):e0136269. PubMed ID: 26308216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate stem cell antigen rs2294008 (C>T) polymorphism and bladder cancer risk: a meta-analysis based on cases and controls.
    Zhao Y; Gui ZL; Liao S; Gao F; Ge YZ; Jia RP
    Genet Mol Res; 2014 Jul; 13(3):5534-40. PubMed ID: 25117309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
    Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
    Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.
    Rai R; Sharma KL; Misra S; Kumar A; Mittal B
    Gene; 2013 Nov; 530(2):172-7. PubMed ID: 23988503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population.
    Qiu LX; Cheng L; He J; Zhou ZR; Wang MY; Zhou F; Guo WJ; Li J; Sun MH; Zhou XY; Wang YN; Yang YJ; Wang JC; Jin L; Zhu XD; Wei QY
    Oncotarget; 2016 Feb; 7(8):9420-8. PubMed ID: 26848528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese.
    Zeng Z; Wu X; Chen F; Yu J; Xue L; Hao Y; Wang Y; Chen M; Sung JJ; Hu P
    Mol Carcinog; 2011 May; 50(5):353-8. PubMed ID: 21268123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of p21 3'UTR gene polymorphism in the risk of prostate cancer: a pilot study.
    Sivoňová MK; Vilčková M; Jurečeková J; Hatok J; Dobrota D; Dušenka R; Kliment J
    Mol Med Rep; 2013 Mar; 7(3):986-90. PubMed ID: 23292332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B; Angaji SA; Abolhasani M
    BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population.
    Lee JH; Song HR; Kim HN; Kweon SS; Yun YW; Choi JS; Jung SI; Kwon DD; Kim SH; Choi YD; Shin MH
    Asian Pac J Cancer Prev; 2014; 15(20):8901-4. PubMed ID: 25374226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
    Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
    Urol Oncol; 2019 Nov; 37(11):814.e9-814.e16. PubMed ID: 31155437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.